Seastar Medical Says Clinical Trial Results Demonstrate Its SCD Significantly Lowered Mortality Rates Among Critically Ill Covid-19 Patients
T-Reuters
2022/06/07
LMF Acquisition Opportunities Inc:Seastar Medical Announces Publication Of Clinical Trial Results Demonstrating Its Scd Significantly Lowered Mortality Rates Among Critically Ill Icu Covid-19 Patients By Safely And Effectively Stopping Inflammation Causing Cytokine Storms.Seastar Medical - Patients Experienced Reductions In Activated Neutrophils And Monocytes.Seastar Medical - Reductions In Activated Neutrophils, Monocytes, Led To Reduction In Proinflammatory Cytokines And Improved Clinical Outcomes.